I
260.71
1.33 (0.51%)
| 前收盘价格 | 259.38 |
| 收盘价格 | 258.75 |
| 成交量 | 465,391 |
| 平均成交量 (3个月) | 795,118 |
| 市值 | 18,308,644,864 |
| 市盈率 (P/E TTM) | 45.03 |
| 预期市盈率 (P/E Forward) | 62.50 |
| 价格/销量 (P/S) | 9.30 |
| 股市价格/股市净资产 (P/B) | 15.11 |
| 52周波幅 | |
| 利润日期 | 8 May 2025 |
| 营业毛利率 | 20.19% |
| 营业利益率 (TTM) | 16.03% |
| 稀释每股收益 (EPS TTM) | 5.79 |
| 季度收入增长率 (YOY) | 17.20% |
| 季度盈利增长率 (YOY) | -2.50% |
| 总债务/股东权益 (D/E MRQ) | 118.37% |
| 流动比率 (MRQ) | 3.58 |
| 营业现金流 (OCF TTM) | 430.30 M |
| 杠杆自由现金流 (LFCF TTM) | 155.28 M |
| 资产报酬率 (ROA TTM) | 6.80% |
| 股东权益报酬率 (ROE TTM) | 43.03% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Devices (US) | 看跌 | 混合的 |
| Medical Devices (全球的) | 看跌 | 混合的 | |
| 股票 | Insulet Corporation | 混合的 | 看涨 |
AIStockmoo 评分
0.6
| 分析师共识 | 2.0 |
| 内部交易活动 | -2.5 |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 0.0 |
| 平均 | 0.60 |
|
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide. |
|
| 部门 | Healthcare |
| 行业 | Medical Devices |
| 投资方式 | Mid Growth |
| 内部持股比例 | 0.38% |
| 机构持股比例 | 102.93% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 355.00 (Citigroup, 36.17%) | 购买 |
| 中 | 324.00 (24.28%) | |
| 低 | 266.00 (Barclays, 2.03%) | 保留 |
| 平均值 | 321.20 (23.20%) | |
| 总计 | 8 购买, 2 保留 | |
| 平均价格@调整类型 | 221.72 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Wolfe Research | 13 May 2025 | 350.00 (34.25%) | 购买 | 0.000 |
| Oppenheimer | 09 May 2025 | 324.00 (24.28%) | 购买 | 0.000 |
| Barclays | 30 Apr 2025 | 266.00 (2.03%) | 保留 | 260.71 |
| RBC Capital | 06 Mar 2025 | 340.00 (30.41%) | 购买 | 259.67 |
| Canaccord Genuity | 21 Feb 2025 | 324.00 (24.28%) | 购买 | 282.80 |
| Citigroup | 21 Feb 2025 | 355.00 (36.17%) | 购买 | 282.80 |
| Piper Sandler | 21 Feb 2025 | 310.00 (18.91%) | 购买 | 282.80 |
| Raymond James | 21 Feb 2025 | 328.00 (25.81%) | 购买 | 282.80 |
| Stifel | 21 Feb 2025 | 293.00 (12.39%) | 保留 | 282.80 |
| Wells Fargo | 21 Feb 2025 | 322.00 (23.51%) | 购买 | 282.80 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| CHADWICK ANA MARIA | - | 260.71 | -1,765 | -460,153 |
| 累积净数量 | -1,765 | |||
| 累积净值 ($) | -460,153 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 260.71 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| CHADWICK ANA MARIA | 职员 | 01 May 2025 | 处理 (-) | 1,765 | 260.71 | 460,153 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合